Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Seasonal Allergic Rhinitis

In brief

The purpose of this study is to examine the safety and efficacy of bepotastine besilate nasal product in seasonal allergic rhinitis patients.

Key facts

Study ID

NCT01222299

Run by

Bausch & Lomb Incorporated

People needed

89

Starts

2010-05-01

Expected to finish

2010-08-01

Last updated by the study team

2020-10-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects 18 to 65 years of age with a positive skin prick test with ragweed allergen

You may not qualify if…

• No active respiratory tract infection

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.